4.6 Article

Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA

Related references

Note: Only part of the references are listed.
Article Substance Abuse

Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation

Lisa Frueh et al.

Summary: This study examines the impact of the COVID-19 pandemic on drug use behaviors among people who use drugs (PWUD) in Rhode Island. The findings highlight the multi-level influences of individual, network, institutional, and policy factors on drug use behaviors and overdose risk.

HARM REDUCTION JOURNAL (2023)

Article Psychology, Clinical

Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19

Robert Rosales et al.

Summary: The COVID-19 pandemic exacerbated health disparities experienced by individuals with opioid use disorder (OUD) from racial and ethnic minority groups, potentially due to disrupted access to harm reduction services. Research findings suggest that persons with OUD who self-identify as from racial/ethnic minority groups are more likely to experience disruptions in accessing harm reduction services, specifically in obtaining naloxone and sterile syringes, even after controlling for confounding variables. This highlights the need for targeted outreach strategies and policies to promote equitable access to essential harm reduction services.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)

Editorial Material Public, Environmental & Occupational Health

The Impact of the COVID-19 Pandemic on Drug Overdose-Related Deaths in the United States and Canada

Vrinda Kalia

AMERICAN JOURNAL OF PUBLIC HEALTH (2022)

Article Substance Abuse

Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020

Czarina N. Behrends et al.

Summary: This study describes the harm reduction and health services provided by U.S syringe services programs (SSPs) in 2019 and the changes in those services in 2020. The results show that most SSPs increased telehealth provision of mental health and primary care services in 2020. They also expanded harm reduction services and the provision of medications for opioid use disorder (MOUD). However, there was a decrease in on-site HIV and HCV testing.

DRUG AND ALCOHOL DEPENDENCE (2022)

Article Substance Abuse

Understanding opioid overdose risk and response preparedness among people who use cocaine and other drugs: Mixed-methods findings from a large, multi-city study

Jaclyn M. W. Hughto et al.

Summary: The study found an increase in fatal overdoses involving cocaine and opioids in Massachusetts. Individuals with no opioid use history were significantly less aware of fentanyl in the drug supply and less prepared with naloxone compared to those with a history of opioid use. Public health efforts are needed to increase awareness and preparedness for overdose prevention among people primarily using cocaine.

SUBSTANCE ABUSE (2022)

Article Substance Abuse

The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months

Alex S. Bennett et al.

Summary: The study found that during the COVID-19 pandemic, people who use illicit opioids were significantly affected, facing difficulties such as obtaining food and mental health issues. The research showed that some participants experienced challenges related to drug supply, but overall, these difficulties diminished as the pandemic progressed, and the number of overdose events decreased.

INTERNATIONAL JOURNAL OF DRUG POLICY (2022)

Editorial Material Medicine, General & Internal

Increases in Disparities in US Drug Overdose Deaths by Race and Ethnicity Opportunities for Clinicians and Health Systems

Mbabazi Kariisa et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Substance Abuse

Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts

Shayla Nolen et al.

Summary: This study reveals racial/ethnic inequities in the access to naloxone in Massachusetts, with minority groups having lower distribution rates compared to white residents. Moreover, naloxone distribution is more likely to occur in racially segregated communities.

DRUG AND ALCOHOL DEPENDENCE (2022)

Review Substance Abuse

Alcohol and other substance use during the COVID-19 pandemic: A systematic review

Amanda Roberts et al.

Summary: The systematic review found that alcohol and other substance use showed different trends during the Covid-19 pandemic. While there was an overall increase in alcohol consumption, the use of other substances also significantly increased. Mental health factors played a key role in the increased use of both alcohol and other substances.

DRUG AND ALCOHOL DEPENDENCE (2021)

Letter Medicine, General & Internal

Racial/Ethnic Disparities in Unintentional Fatal and Nonfatal Emergency Medical Services-Attended Opioid Overdoses During the COVID-19 Pandemic in Philadelphia

Utsha G. Khatri et al.

Summary: This study investigates the differential associations of the COVID-19 pandemic with opioid-related overdoses among racial/ethnic groups in Philadelphia, Pennsylvania.

JAMA NETWORK OPEN (2021)

Article Public, Environmental & Occupational Health

Growing racial/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California

Joseph Friedman et al.

Summary: During the COVID-19 pandemic, overdose mortality rates have surged, with all racial/ethnic groups surpassing expected trends. Particularly concerning is the rapid increase in overdose mortality rates in Black and Latinx communities. In California, Black individuals saw a higher overdose mortality rate compared to White individuals, reflecting a growing disparity that calls for increased attention and investment in addressing racial disparities in substance use treatment and harm reduction.

PREVENTIVE MEDICINE (2021)

Article Substance Abuse

Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island

Xiao Zang et al.

Summary: The study compared naloxone distribution and opioid overdose death rates in Massachusetts and Rhode Island from 2016 to 2019, identifying improvements in both states with a faster rate in Rhode Island. Urban areas showed higher naloxone distribution relative to opioid overdose deaths, while some counties had high overdose death rates but low naloxone availability through OEND programs.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

Article Psychology, Clinical

Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder

Colleen B. Mistler et al.

Summary: The COVID-19 pandemic has worsened health disparities, especially among individuals with opioid use disorder (OUD). Findings show negative impacts of COVID-19 on people with OUD, including emotional issues and decreased financial stability. Significant differences by race/ethnicity highlight the need for tailored interventions.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Article Public, Environmental & Occupational Health

Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018-2019, From the HEALing Communities Study

Marc R. Larochelle et al.

Summary: The study found that opioid overdose death rates remained stable from 2018 to 2019 across 67 HEALing Communities Study communities, with a significant increase among non-Hispanic Black individuals. An anti-racist public health approach is needed to address this crisis of opioid-related harms.

AMERICAN JOURNAL OF PUBLIC HEALTH (2021)

Article Substance Abuse

The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services

Yesenia Aponte-Melendez et al.

Summary: The study found that during the COVID-19 pandemic, PWID in New York City reported higher levels of mental health issues, syringe reuse, alcohol consumption, and significant reductions in syringe-service programs and buprenorphine utilization. Additionally, there were differences between study groups, with the AC group reporting lower levels of substance use and injection risk behaviors during the pandemic.

HARM REDUCTION JOURNAL (2021)

Article Substance Abuse

The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA

Elizabeth N. Kinnard et al.

Summary: The study revealed that people of color and individuals experiencing homelessness were less likely to receive naloxone in the past six months, while those who used opioids more frequently and witnessed overdoses were more likely to receive naloxone.

DRUG AND ALCOHOL DEPENDENCE (2021)

Review Substance Abuse

The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data

Sameer Imtiaz et al.

Summary: The study found that drug overdose-related deaths in North America increased after the onset of the COVID-19 pandemic. In response to this situation, a multi-pronged approach is necessary, including expanded access to substance use disorder treatment, undisrupted access to harm reduction services, emphasis on risk reduction strategies, provision of a safe drug supply, and decriminalization of drug use.

SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2021)

Letter Health Care Sciences & Services

Trends in Filled Naloxone Prescriptions Before and During the COVID-19 Pandemic in the United States

Ashley L. O'Donoghue et al.

Summary: This cohort study examines the trends in filled naloxone prescriptions in the United States during the COVID-19 pandemic and compares them to opioid prescriptions and total prescriptions.

JAMA HEALTH FORUM (2021)

Article Psychology, Clinical

A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose

Benjamin P. Linas et al.

Summary: COVID-19 has a lasting impact on public health, not only through direct effects of infection but also through the indirect effects of physical distancing measures on people living with opioid use disorder. It is crucial to monitor the impact of COVID-19 on the opioid epidemic and the potential mechanisms discussed in the study.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)

Article Public, Environmental & Occupational Health

Assessing differential impacts of COVID-19 on black communities

Gregorio A. Millett et al.

ANNALS OF EPIDEMIOLOGY (2020)

Editorial Material Medicine, General & Internal

COVID-19 and African Americans

Clyde W. Yancy

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Substance Abuse

Opioid Use Disorder and COVID-19: Crashing of the Crises

Utsha G. Khatri et al.

JOURNAL OF ADDICTION MEDICINE (2020)

Article Substance Abuse

Understanding and using time series analyses in addiction research

Emma Beard et al.

ADDICTION (2019)

Article Social Sciences, Biomedical

White opioids: Pharmaceutical race and the war on drugs that wasn't

Julie Netherland et al.

BIOSOCIETIES (2017)

Article Health Care Sciences & Services

Simulation-based power calculation for designing interrupted time series analyses of health policy interventions

Fang Zhang et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Public, Environmental & Occupational Health

Airborne particulate matter and mortality: Timescale effects in four US cities

F Dominici et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)